COVID-19 in adults with dementia: clinical features and risk factors of mortality—a clinical cohort study on 125 patients
Abstract Background There is limited evidence on the characteristics and outcome of patients with dementia hospitalised for novel coronavirus infection (COVID-19). Method We conducted a prospective study in 2 gerontologic COVID units in Paris, France, from March 14, 2020, to May 7, 2020. Patients wi...
Main Authors: | Agathe Vrillon, Elsa Mhanna, Clément Aveneau, Manon Lebozec, Lina Grosset, Diane Nankam, Fernanda Albuquerque, Raphaelle Razou Feroldi, Barbara Maakaroun, Iana Pissareva, Dalenda Cherni Gherissi, Julien Azuar, Véronique François, Claire Hourrègue, Julien Dumurgier, Lisette Volpe-Gillot, Claire Paquet |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-04-01
|
Series: | Alzheimer’s Research & Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13195-021-00820-9 |
Similar Items
-
PKR involvement in Alzheimer’s disease
by: Jacques Hugon, et al.
Published: (2017-10-01) -
Pro-apoptotic kinases levels in cerebrospinal fluid as potential future biomarkers in Alzheimer’s Disease
by: Claire ePAQUET, et al.
Published: (2015-08-01) -
Full-length and C-terminal neurogranin in Alzheimer’s disease cerebrospinal fluid analyzed by novel ultrasensitive immunoassays
by: Annika Öhrfelt, et al.
Published: (2020-12-01) -
Blood-Based Kinase Assessments in Alzheimer’s Disease
by: Jacques Hugon, et al.
Published: (2018-11-01) -
Neurofilaments as Emerging Biomarkers of Neuroaxonal sDamage to Differentiate Behavioral Frontotemporal Dementia from Primary Psychiatric Disorders: A Systematic Review
by: Vincent Davy, et al.
Published: (2021-04-01)